التفاصيل البيبلوغرافية
| العنوان: |
P-88 First-Line Pembrolizumab With or Without Lenvatinib in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC): Phase 3 LEAP-010 Study. |
| المؤلفون: |
Harrington, Kevin1 (AUTHOR), Siu, Lillian L.2 (AUTHOR), Burtness, Barbara3 (AUTHOR), Cohen, Ezra4 (AUTHOR), Licitra, Lisa5 (AUTHOR), Rischin, Danny6 (AUTHOR), Zhu, Ying7 (AUTHOR), Okpara, Chinyere E.8 (AUTHOR), Pinheiro, Cecilia7 (AUTHOR), Swaby, Ramona F.7 (AUTHOR), Machiels, Jean-Pascal9 (AUTHOR), Tahara, Makoto10 (AUTHOR) |
| المصدر: |
Oral Oncology. 2021 Supplement, Vol. 118, p7-8. 2p. |
| مصطلحات موضوعية: |
*SQUAMOUS cell carcinoma, *PEMBROLIZUMAB, *METASTASIS, *NECK, *HEAD |
| قاعدة البيانات: |
Academic Search Index |
